We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-UK will have public guidelines for Brexit talks before triggering Article 50 - minister

Mon, 12th Sep 2016 18:55

(Recasts, adds quotes, context)

By William James

LONDON, Sept 12 (Reuters) - Britain will make public itsguidelines for talks on leaving the European Union by the timeit triggers the exit process, Brexit minister David Davis saidon Monday, in the first indication of when Britons will find outwhat the government hopes to achieve in the talks.

Prime Minister Theresa May's government has warned it willreveal little about its strategy on key issues like immigrationand trade as it prepares to negotiate Britain's exit from the EUfollowing the shock June 23 referendum vote to leave.

But Davis, head of the newly created Department for Exitingthe European Union, said the negotiating process itself wouldnot be a "black box" and that details would begin to emerge oncethe legal exit procedure, known as 'Article 50' began.

"It will start, I guess, at the point of triggering Article50. We will at that point have a some clear public negotiatingguidelines," David told a committee of lawmakers investigatingthe role of parliament in the Brexit process.

The government has been pressed for detailed answers on howit intends to enact the decision to quit the bloc by everyonefrom business leaders to foreign allies.

So far, it has revealed little.

"Before Article 50 is triggered there will be a ratherfrustrating time, because we won't be saying an awful lot,"Davis said. He said giving a running commentary on the talkswould undermine Britain's negotiating stance.

Separately, finance minister Philip Hammond sought toaddress the concerns of businesses about Brexit, meeting withlarge exporters like Honda, Airbus andGlaxoSmithKline to tell them that trade with EU memberstates would be a priority in the exit talks.

FAST AND RESPONSIVE

Once the exit process has been started, Britain has aninitial two-year period to negotiate its departure. Davis saidthis time frame was possible, but would require the governmentto be "nimble, fast and responsive." The talks can be extendedif both parties agree.

Davis said parliament would be called upon to pass new lawsto enact the exit from the bloc. The government has previouslystated parliament did not need to approve the decision totrigger an exit.

He said the negotiating strategy would be drawn up byassessing feedback from other government departments which havebeen asked to consult with relevant parties on the opportunitiesbrought about by leaving, the risks of leaving, and bestpolicies to mitigate those risks.

"At that point, which is not yet, we will be doing somequite quantitative assessment of what we think the advantagesand disadvantages are," he said. "We need to take an empiricalapproach. The purpose of this is not to damage the nationalinterest or damage economic interest, it's just the reverse." (Additional reporting by Estelle Shirbon and Elizabeth Piper;Editing by Hugh Lawson)

More News
Today 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
Today 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.